Johnson & Johnson Business Finance Contracts & Agreements

57 Contracts & Agreements
Browse by Subcategory
Recent Contracts
Category
Company
Industry
Jur. Jurisdiction
Filed
Johnson & Johnson 3.700% Note Due 2055 (Indenture Debt Security Certificate)
Note Agreements
Johnson & Johnson
Pharmaceuticals
NJ
2025
Johnson & Johnson 3.600% Note Due 2045 Issued Under Indenture to The Bank of New York Mellon Trust Company
Note Agreements
Johnson & Johnson
Pharmaceuticals
NJ
2025
Johnson & Johnson 3.350% Note Due 2037 (Indenture Debt Security Certificate)
Note Agreements
Johnson & Johnson
Pharmaceuticals
NJ
2025
Johnson & Johnson 3.050% Note Due 2033 Issued to The Bank of New York Depository (Nominees) Limited
Note Agreements
Johnson & Johnson
Pharmaceuticals
NJ
2025
Johnson & Johnson 2.700% Note Due 2029 Issued to The Bank of New York Depository (Nominees) Limited
Note Agreements
Johnson & Johnson
Pharmaceuticals
NJ
2025
Johnson & Johnson Company Order for Issuance of Euro-Denominated Notes (2029–2055)
Note Agreements
Johnson & Johnson
Pharmaceuticals
2025
Underwriting Agreement for Johnson & Johnson €4 Billion Notes Offering (2029–2055)
Underwriting Agreements
Johnson & Johnson
Pharmaceuticals
NY
2025
Johnson & Johnson 5.000% Note Due 2035 (Indenture Debt Security Certificate)
Note Agreements
Johnson & Johnson
Pharmaceuticals
NJ
2025
Johnson & Johnson 4.850% Note Due 2032 (Indenture Debt Security)
Note Agreements
Johnson & Johnson
Pharmaceuticals
NJ
2025
Johnson & Johnson 4.700% Note Due 2030 (Global Note)
Note Agreements
Johnson & Johnson
Pharmaceuticals
NJ
2025
Johnson & Johnson 4.550% Note Due 2028 (Indenture Debt Security Certificate)
Note Agreements
Johnson & Johnson
Pharmaceuticals
NJ
2025
Johnson & Johnson 4.500% Note Due 2027 (Global Note)
Note Agreements
Johnson & Johnson
Pharmaceuticals
NJ
2025
Johnson & Johnson Company Order for Issuance of Series Notes under Indenture (2025)
Indenture Agreements
Johnson & Johnson
Pharmaceuticals
2025
Johnson & Johnson Standard Underwriting Agreement Provisions (Debt) – February 2025
Underwriting Agreements
Johnson & Johnson
Pharmaceuticals
2025
Underwriting Agreement for Johnson & Johnson $5 Billion Notes Offering (2027–2035) with Citigroup, BofA, J.P. Morgan, and Others
Underwriting Agreements
Johnson & Johnson
Pharmaceuticals
2025
Johnson & Johnson Underwriting Agreement for €2.5 Billion Notes Offering (2024)
Underwriting Agreements
Johnson & Johnson
Pharmaceuticals
NY
2024
Johnson & Johnson Standard Debt Underwriting Agreement Provisions (May 2024)
Underwriting Agreements
Johnson & Johnson
Pharmaceuticals
2024
Johnson & Johnson Underwriting Agreement for $4 Billion Notes Offering (2024)
Underwriting Agreements
Johnson & Johnson
Pharmaceuticals
2024
Registration Rights Agreement between Johnson & Johnson and Kenvue Inc. dated May 3, 2023
Registration Rights Agreements
Johnson & Johnson
Pharmaceuticals
DE
2023
Contingent Value Rights Agreement between Johnson & Johnson and American Stock Transfer & Trust Company, LLC (December 22, 2022)
Stock Agreements
Johnson & Johnson
Pharmaceuticals
DE
2022
Johnson & Johnson Standard Underwriting Agreement Provisions (Debt)
Underwriting Agreements
Johnson & Johnson
Pharmaceuticals
2020
Description of Johnson & Johnson Capital Stock and Debt Securities Registered Under Section 12 of the Exchange Act
Equity Distribution Agreements
Johnson & Johnson
Pharmaceuticals
NY
2020
Johnson & Johnson 2012 Long-Term Incentive Plan Global Nonqualified Stock Option Award Agreement
Warrant Agreements
Johnson & Johnson
Pharmaceuticals
CA
2018
Second Supplemental Indenture between Johnson & Johnson and The Bank of New York Mellon Trust Company, N.A. (November 9, 2017)
Indenture Agreements
Johnson & Johnson
Pharmaceuticals
NY
2017
Johnson & Johnson Standard Underwriting Agreement Provisions (Debt)
Underwriting Agreements
Johnson & Johnson
Pharmaceuticals
2017
Johnson & Johnson 3.550% Note Due 2044 (Indenture Debt Security)
Note Agreements
Johnson & Johnson
Pharmaceuticals
NJ
2024
Johnson & Johnson 3.350% Note Due 2036 (Indenture Debt Security)
Note Agreements
Johnson & Johnson
Pharmaceuticals
NJ
2024
Johnson & Johnson 3.200% Note Due 2032 (Euro) – The Bank of New York Depository (Nominees) Limited
Note Agreements
Johnson & Johnson
Pharmaceuticals
NJ
2024
Johnson & Johnson Order for Issuance of Euro-Denominated Notes Due 2032, 2036, and 2044
Note Agreements
Johnson & Johnson
Pharmaceuticals
2024
Johnson & Johnson 5.250% Note Due 2054 (Indenture Debt Security Certificate)
Note Agreements
Johnson & Johnson
Pharmaceuticals
NJ
2024
Johnson & Johnson 4.950% Note Due 2034 (Indenture Debt Security)
Note Agreements
Johnson & Johnson
Pharmaceuticals
NJ
2024
Johnson & Johnson 4.900% Note Due 2031 (Indenture Debt Security Certificate)
Note Agreements
Johnson & Johnson
Pharmaceuticals
NJ
2024
Johnson & Johnson 4.800% Note Due 2029 (Indenture Debt Security Certificate)
Note Agreements
Johnson & Johnson
Pharmaceuticals
NJ
2024
Johnson & Johnson Order for Issuance of Series Notes under Indenture (May 2024)
Note Agreements
Johnson & Johnson
Pharmaceuticals
2024
Johnson & Johnson Company Order for Issuance of Series Notes (2025–2060)
Note Agreements
Johnson & Johnson
Pharmaceuticals
2020
Johnson & Johnson Order for Issuance of Series Notes under Indenture (November 2017)
Note Agreements
Johnson & Johnson
Pharmaceuticals
2017
Johnson & Johnson Company Order for Issuance of Notes under Indenture (February 2017)
Note Agreements
Johnson & Johnson
Pharmaceuticals
2017
Johnson & Johnson 1.650% Note Due 2035 Issued to The Bank of New York Depository (Nominees) Limited
Note Agreements
Johnson & Johnson
Pharmaceuticals
NJ
2016
Johnson & Johnson 1.150% Note Due 2028 Issued to The Bank of New York Depository (Nominees) Limited
Note Agreements
Johnson & Johnson
Pharmaceuticals
NJ
2016
Johnson & Johnson 0.650% Note Due 2024 Issued to The Bank of New York Depository (Nominees) Limited
Note Agreements
Johnson & Johnson
Pharmaceuticals
NJ
2016